Journal of Cataract & Refractive Surgery
Volume 31, Issue 4 , Pages 735-741 , April 2005

Cohort study of 27 cases of endophthalmitis at a single institution

,Accepted 12 October 2004.

References 

  1. Javitt JC, Vitale S, Canner JK, et al. National outcomes of cataract extraction; endophthalmitis following inpatient surgery. Arch Ophthalmol. 1991;109:1085–1089
  2. Nagaki Y, Hayasaka S, Kodoi C, et al. Bacterial endophthalmitis after small-incision cataract surgery: effect of incision placement and intraocular lens type. J Cataract Refract Surg. 2003;29:20–26
  3. Jensen MK, Fiscella RG, Crandall AS, et al. A retrospective study of endophthalmitis rates comparing quinolone antibiotics. Am J Ophthalmol. 2005;139:141–148
  4. Baum J, Barza M. The evolution of antibiotic therapy for bacterial conjunctivitis and keratitis: 1970–2000. Cornea. 2000;19:659–672
  5. Çekiç O, Batman C, Totan Y, et al. Aqueous humor levels of topically applied ciprofloxacin and ofloxacin in the same subjects. Eye. 1999;13:656–659
  6. Bucci FA, O'Brien TP, Evans RE, Myers PJ. A prospective comparison of four methods of pre-phacoemulsification antibiotic treatment with ofloxacin and ciprofloxacin. ARVO abstract 4072. Invest Ophthalmol Vis Sci. 2000;41(4):5768
  7. Kunimoto DY, Sharma S, Garg P, Rao GN. In vitro susceptibility of bacterial keratitis pathogens to ciprofloxacin; emerging resistance. Ophthalmology. 1999;106:80–85
  8. Goldstein MH, Kowalsk RP, Gordon YJ. Emerging fluoroquinolone resistance in bacterial keratitis; a 5-year review. Ophthalmology. 1999;106:1313–1318
  9. Speaker MG, Menikoff JA. Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology. 1991;98:1769–1795
  10. Isenberg SJ, Apt L, Yoshimori R, Khwarg S. Chemical preparation of the eye in ophthalmic surgery. IV. Comparison of povidone-iodine on the conjunctiva with a prophylactic antibiotic. Arch Ophthalmol. 1985;103:1340–1342
  11. Endophthalmitis Vitrectomy Study Group . Results of the Endophthalmitis Vitrectomy Study; a randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol. 1995;113:1479–1496
  12. Kresloff MS, Castellarin AA, Zarbin MA. Endophthalmitis. Surv Ophthalmol. 1998;43:193–224

 Supported in part by a grant from Research to Prevent Blindness, Inc., New York, New York, USA, to the Department of Ophthalmology and Visual Sciences, University of Utah.Dr. Olson is a consultant to Allergan, Inc. No other author has a proprietary or commercial interest in any product mentioned.

PII: S0886-3350(04)01227-1

doi: 10.1016/j.jcrs.2004.10.057

Journal of Cataract & Refractive Surgery
Volume 31, Issue 4 , Pages 735-741 , April 2005

Article Tools